Product
GE-IR 450 mg + Oxycodone 20 mg
1 clinical trial
1 indication
Indication
Abuse PotentialClinical trial
A Randomized, Double-blind, Active- and Placebo-controlled, 6-way Crossover Study to Evaluate the Abuse Potential of Orally Administered Gabapentin Enacarbil Immediate Release Capsules Taken Alone and in Combination With Oxycodone in Healthy, Nondependent, Recreational Opioid UsersStatus: Completed, Estimated PCD: 2023-04-25